Redmile Group’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-78,755
Closed -$63K 95
2020
Q2
$63K Hold
78,755
﹤0.01% 79
2020
Q1
$54K Hold
78,755
﹤0.01% 68
2019
Q4
$124K Hold
78,755
﹤0.01% 63
2019
Q3
$313K Hold
78,755
0.01% 63
2019
Q2
$570K Sell
78,755
-1
-0% -$7 0.02% 69
2019
Q1
$521K Sell
78,756
-1,292
-2% -$8.51K 0.02% 69
2018
Q4
$575K Sell
80,048
-998
-1% -$11.1K 0.02% 65
2018
Q3
$1.55M Sell
81,046
-351,593
-81% -$12.5M 0.05% 68
2018
Q2
$24.5M Sell
432,639
-159,677
-27% -$8.1M 0.83% 43
2018
Q1
$25.1M Sell
592,316
-494
-0.1% -$21.2K 0.97% 34
2017
Q4
$31.7M Sell
592,810
-61,658
-9% -$3.26M 1.38% 27
2017
Q3
$29.2M Buy
654,468
+17,638
+3% +$804K 1.44% 25
2017
Q2
$30.9M Buy
636,830
+365,091
+134% +$21.5M 1.88% 19
2017
Q1
$19.7M Buy
271,739
+151,050
+125% +$9.99M 1.28% 30
2016
Q4
$6.9M Sell
120,689
-227,375
-65% -$20.8M 0.6% 36
2016
Q3
$44.6M Sell
348,064
-48,211
-12% -$6.17M 3.54% 9
2016
Q2
$49.4M Buy
396,275
+149,390
+61% +$17.2M 4.72% 7
2016
Q1
$20.6M Buy
246,885
+146,167
+145% +$12M 2.11% 19
2015
Q4
$9.97M Buy
+100,718
New +$10.8M 0.75% 30
2014
Q2
Sell
-79,510
Closed -$10.2M 65
2014
Q1
$10.2M Buy
79,510
+47,937
+152% +$7.45M 1.22% 34
2013
Q4
$5.51M Buy
+31,573
New +$5.43M 0.68% 44

Other funds holding ELGX

Redmile Group's ELGX Position: Q3 2020 in Review

Redmile Group sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 78,755 shares — an estimated $63K sold.

Redmile Group first reported a position in ELGX in Q4 2013 and held it in 21 quarters. The position peaked at $49.4M in Q2 2016. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.

  • Redmile Group reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
  • Redmile Group sold 78,755 Endologix Inc shares in Q3 2020, an estimated $63K.
  • Redmile Group first reported a position in Endologix Inc in Q4 2013 and held it in 21 quarters.
  • Redmile Group's Endologix Inc position peaked at $49.4M in Q2 2016.
  • 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.

Based on Redmile Group's 13F filing for Q3 2020, filed 16 Nov 2020.